Ang G, Brown L, Tam S, Davies K, Foster R, Harrison P
Transl Psychiatry. 2021; 11(1):588.
PMID: 34782594
PMC: 8593011.
DOI: 10.1038/s41398-021-01690-3.
Millard S, Bearden C, Karlsgodt K, Sharpe M
Neuropsychopharmacology. 2021; 47(3):628-640.
PMID: 34588607
PMC: 8782867.
DOI: 10.1038/s41386-021-01188-y.
Granger K, Ferrar J, Caswell S, Haselgrove M, Moran P, Attwood A
Front Psychiatry. 2021; 12:582745.
PMID: 33935819
PMC: 8085318.
DOI: 10.3389/fpsyt.2021.582745.
Ibi D, Yamada K
Int J Mol Sci. 2015; 16(12):28218-29.
PMID: 26633355
PMC: 4691039.
DOI: 10.3390/ijms161226092.
Brzozka M, Rossner M, de Hoz L
Eur Arch Psychiatry Clin Neurosci. 2015; 266(6):505-12.
PMID: 26404636
DOI: 10.1007/s00406-015-0643-8.
Impact of prenatal environmental stress on cortical development.
Ishii S, Hashimoto-Torii K
Front Cell Neurosci. 2015; 9:207.
PMID: 26074774
PMC: 4444817.
DOI: 10.3389/fncel.2015.00207.
Cognitive judgment bias in the psychostimulant-induced model of mania in rats.
Rygula R, Szczech E, Kregiel J, Golebiowska J, Kubik J, Popik P
Psychopharmacology (Berl). 2014; 232(3):651-60.
PMID: 25116482
PMC: 4302237.
DOI: 10.1007/s00213-014-3707-y.
Accounting for individual differences in human associative learning.
Byrom N
Front Psychol. 2013; 4:588.
PMID: 24027551
PMC: 3761215.
DOI: 10.3389/fpsyg.2013.00588.
Paradoxical effects of low dose MDMA on latent inhibition in the rat.
Nelson A, Thur K, Marsden C, Cassaday H
Neuropharmacology. 2012; 67:331-6.
PMID: 23201353
PMC: 3574236.
DOI: 10.1016/j.neuropharm.2012.11.012.
Dopamine D1 receptor involvement in latent inhibition and overshadowing.
Nelson A, Thur K, Cassaday H
Int J Neuropsychopharmacol. 2011; 15(10):1513-23.
PMID: 22176724
PMC: 3496172.
DOI: 10.1017/S1461145711001751.
Opposing effects of 5,7-DHT lesions to the core and shell of the nucleus accumbens on the processing of irrelevant stimuli.
Nelson A, Thur K, Marsden C, Cassaday H
Int J Neuropsychopharmacol. 2011; 15(4):485-96.
PMID: 21557885
PMC: 3325501.
DOI: 10.1017/S1461145711000599.
New translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and rats.
Bussey T, Holmes A, Lyon L, Mar A, McAllister K, Nithianantharajah J
Neuropharmacology. 2011; 62(3):1191-203.
PMID: 21530550
PMC: 3168710.
DOI: 10.1016/j.neuropharm.2011.04.011.
Dopamine in nucleus accumbens: salience modulation in latent inhibition and overshadowing.
Nelson A, Thur K, Marsden C, Cassaday H
J Psychopharmacol. 2011; 25(12):1649-60.
PMID: 21262855
PMC: 3267554.
DOI: 10.1177/0269881110389211.
Reduced dopamine function within the medial shell of the nucleus accumbens enhances latent inhibition.
Nelson A, Thur K, Horsley R, Spicer C, Marsden C, Cassaday H
Pharmacol Biochem Behav. 2010; 98(1):1-7.
PMID: 21146557
PMC: 3038261.
DOI: 10.1016/j.pbb.2010.11.025.
Catecholaminergic depletion within the prelimbic medial prefrontal cortex enhances latent inhibition.
Nelson A, Thur K, Marsden C, Cassaday H
Neuroscience. 2010; 170(1):99-106.
PMID: 20619321
PMC: 2930211.
DOI: 10.1016/j.neuroscience.2010.06.066.
Assessing the construct validity of aberrant salience.
Schmidt K, Roiser J
Front Behav Neurosci. 2010; 3:58.
PMID: 20057930
PMC: 2802547.
DOI: 10.3389/neuro.08.058.2009.
Disruption of the US pre-exposure effect and latent inhibition in two-way active avoidance by systemic amphetamine in C57BL/6 mice.
Chang T, Meyer U, Feldon J, Yee B
Psychopharmacology (Berl). 2006; 191(2):211-21.
PMID: 17180617
DOI: 10.1007/s00213-006-0649-z.
The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance.
Silber B, Croft R, Papafotiou K, Stough C
Psychopharmacology (Berl). 2006; 187(2):154-69.
PMID: 16761129
DOI: 10.1007/s00213-006-0410-7.
Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile.
Yee B, Balic E, Singer P, Schwerdel C, Grampp T, Gabernet L
J Neurosci. 2006; 26(12):3169-81.
PMID: 16554468
PMC: 6674096.
DOI: 10.1523/JNEUROSCI.5120-05.2006.
Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition.
Tenn C, Kapur S, Fletcher P
Psychopharmacology (Berl). 2005; 180(2):366-76.
PMID: 15856186
DOI: 10.1007/s00213-005-2253-z.